Institutional Ownership Denali Therapeutics Inc. (DNLI)
This table provides information about the institutional ownership of Denali Therapeutics Inc. (DNLI). We have compiled data on the 234 institutions that hold shares in the stock, with a total of 127 Million shares, which have been reported (via 13F filing form) to have a value of $1.7 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,174,562
shares
|
$177 Million
0.01% of portfolio
|
Q2 2024
Added 7.99%
|
|
Baillie Gifford & CO
|
May 07, 2025 Q1 2025 |
12,090,040
shares
|
$162 Million
0.15% of portfolio
|
Q1 2025
Reduced 1.82%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
11,799,757
shares
|
$158 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.84%
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
11,409,598
shares
|
$153 Million
0.03% of portfolio
|
Q1 2025
New holding
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
6,766,916
shares
|
$90.8 Million
0.02% of portfolio
|
Q1 2025
Added 88.87%
|
|
Temasek Holdings (Private) LTD
Singapore, U0 |
May 16, 2025 Q1 2025 |
5,355,832
shares
|
$71.9 Million
0.37% of portfolio
|
Q3 2024
New holding
|
|
Capital Research Global Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
4,765,137
shares
|
$63.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 13.0%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
4,460,757
shares
|
$59.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.85%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
4,367,234
shares
|
$58.6 Million
0.01% of portfolio
|
Q1 2025
Added 42.78%
|
|
Crestline Management, LP
Fort Worth, TX |
May 15, 2025 Q1 2025 |
4,160,732
shares
|
$55.8 Million
89.45% of portfolio
|
Q1 2025
Reduced 3.48%
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
3,731,695
shares
|
$50.1 Million
0.6% of portfolio
|
Q1 2024
Added 43.13%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
3,154,387
shares
|
$42.3 Million
0.02% of portfolio
|
Q1 2025
Reduced 4.86%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
3,037,176
shares
|
$40.8 Million
0.0% of portfolio
|
Q1 2025
Added 3.47%
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
2,188,422
shares
|
$29.4 Million
0.04% of portfolio
|
Q1 2025
Added 22.34%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
2,100,856
shares
|
$28.2 Million
0.01% of portfolio
|
Q1 2025
Added 13.25%
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
1,672,078
shares
|
$22.4 Million
0.0% of portfolio
|
Q1 2025
Added 58.11%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,566,246
shares
|
$21 Million
0.03% of portfolio
|
Q1 2024
Reduced 0.63%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
1,493,068
shares
|
$20 Million
0.01% of portfolio
|
Q1 2025
Added 269.37%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
May 14, 2025 Q1 2025 |
1,364,959
shares
|
$18.3 Million
0.01% of portfolio
|
Q1 2025
Added 72.23%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,253,603
shares
|
$16.8 Million
0.0% of portfolio
|
Q1 2025
Added 1.99%
|
|
Camber Capital Management LP
Boston, MA |
May 15, 2025 Q1 2025 |
1,250,000
shares
|
$16.8 Million
0.64% of portfolio
|
Q1 2025
Reduced 44.44%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
1,169,683
shares
|
$15.7 Million
0.0% of portfolio
|
Q1 2025
Added 40.94%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,132,173
shares
|
$15.2 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.77%
|
|
Principal Financial Group Inc
Des Moines, IA |
Apr 28, 2025 Q1 2025 |
1,081,578
shares
|
$14.5 Million
0.01% of portfolio
|
Q1 2025
Reduced 4.37%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,027,977
shares
|
$13.8 Million
0.04% of portfolio
|
Q2 2023
Reduced 17.66%
|